EUVIMEDEUVIMED entdecken
Crossref

Isofraxidin Attenuates Ischemia/Reperfusion‐Induced Neuroinflammation and Oxidative Stress Via Modulation of the TLR4/NF‐κB Signaling Pathway in Male Animal Model

Long Su, Xiaofang Hu, Ankit Kumar, Li Yang iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Long Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, XD Group Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Reperfusion Injury, NF-kappa B, Signal Transduction, Oxidative Stress. Die Arbeit nennt 74 Literaturangaben. Gefördert von: This study was funded by the Key Research and Development Program of Shaanxi Province: Social Development Grant No. (2024SF-YBXM-052)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral ischemia reperfusion (CIR) is a condition of brain, which is occurred due to insufficient supply of blood. Isofraxidin is a naturally occurring coumarin derivative which showed the strong anti‐inflammatory and antioxidant effect in various disease animal models. Its neuroprotective effects against ischemia/reperfusion (I/R)‐mediated injuries, however, have not been investigated. The current study was to scrutinize the neuroprotective effect of Isofraxidin against the CIR in rats.

Methods

The Swiss Albino Wistar rats (sex‐male, 42 rats) were randomly selected for this study and transient occlusion of the middle cerebral artery was performed (1 h) for the induction of ischemia followed by reperfusion (24 h). Neurological score, brain water content, brain edema, infarct volume, nitric oxide (NO), myeloperoxidase (MPO), evans blue leakage, antioxidant, inflammatory, cytokines parameters and matrix metalloproteinases (MMP) level were estimated.

Results

Isofraxidin (7.5, 15 and 30 mg/kg) suppressed the brain edema (56.93%, 33.92%, 12.9%) neurological score (3.37, 2.76, 1.5), infarct volume (40.43%, 23.08%, 13.02%), evans blue leakage (4.32 μg/g tissue, 2.68 μg/g tissue, 1.35 μg/g tissue) and brain water content (72.95%, 54.66%, 40.38%) in the CIR group rats. CIR rats treated with Isofraxidin (7.5, 15 and 30 mg/kg) significantly ( p < 0.001) altered the level of clusterin (305.17 μg/mL, 197 μg/mL, 110.65 μg/mL), neuron‐specific enolase (14.04 ng/mL, 8.08 ng/mL, 6.02 ng/mL), NO (0.78 μmol/mg, 0.51 μmol/mg, 0.39 μmol/mg) and MPO (1.81 U/mg protein, 1.41 U/mg protein, 0.87 U/mg protein) along with the modulation of antioxidant parameters. Isofraxidin (7.5, 15 and 30 mg/kg) significantly ( p < 0.001) altered the level of cytokines such as tumor necrosis factor‐α (29.53 pg/mg, 19.55 pg/mg, 11.52 pg/mg), interleukin‐1β (19.22 pg/mg, 12.36 pg/mg, 7.01 pg/mg), 2 (234.33 pg/mg, 151.66 pg/mg, 71.27 pg/mg), 6 (37.23 pg/mg, 30.55 pg/mg, 21.91 pg/mg), 9 (89.06 pg/mg, 48.51 pg/mg, 26.29 pg/mg) and 10 (10.98 pg/mg, 19.38 pg/mg, 28.86 pg/mg). CIR group rats treated with isofraxidin (7.5, 15 and 30 mg/kg) decreased the level of cyclooxygenase‐2 (32.05 pg/mg, 19.91 pg/mg, 12.83 pg/mg), prostaglandin (33.88 pg/mg, 21.01 pg/mg, 12.13 pg/mg), inducible nitric oxide (31.01 pg/mg, 19.51 pg/mg, 10.16 pg/mg), vascular endothelial growth factor (41.71 pg/mg, 28.55 pg/mg, 16.19 pg/mg) and nuclear kappa B factor (52.91 pg/mg, 36.16 pg/mg, 16.17 pg/mg), respectively. Isofraxidin (7.5, 15 and 30 mg/kg) treatment altered the mRNA expression of COX‐2, LOX‐1, iNOS, NF‐κB, Bax, Bcl‐2, caspase‐3, TRL4, syndecan‐1, CSF, aquaportin‐1, OCT3 and RFX1.

Conclusion

Isofraxidin treatment exhibited brain protective against cerebral ischemia reperfusion via suppression of free radical and inflammatory reaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryNF-kappa BSignal TransductionOxidative StressCoumarinsNeuroinflammatory DiseasesToll-Like Receptor 4Neuroprotective AgentsBrain IschemiaAnimalsMaleRats, WistarRatsDisease Models, Animal

Stichwörter der Autor:innen

cerebral ischemia reperfusioninflammationioxidative stresssofraxidin

Substanzen

NF-kappa BCoumarinsToll-Like Receptor 4isofraxidinTlr4 protein, ratNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, XD Group Hospital, Xi'an, China.
  • Department of Neurology, Shandong Public Health Clinical Center, Shandong University, Jinan, China.
  • Department of Pharmacology, Venkateshwara College of Pharmacy, Meerut, India.
  • Department of Neurology, Baoshan People's Hospital, Baoshan, China.

ORCID-Profile: Li Yang

Förderung

  • This study was funded by the Key Research and Development Program of Shaanxi Province: Social Development Grant No. (2024SF-YBXM-052).

Zitieren

APA

Su, L., Hu, X., Kumar, A., & Yang, L. (2025). Isofraxidin Attenuates Ischemia/Reperfusion‐Induced Neuroinflammation and Oxidative Stress Via Modulation of the TLR4/NF‐κB Signaling Pathway in Male Animal Model. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70555

Vancouver

Su L, Hu X, Kumar A, Yang L. Isofraxidin Attenuates Ischemia/Reperfusion‐Induced Neuroinflammation and Oxidative Stress Via Modulation of the TLR4/NF‐κB Signaling Pathway in Male Animal Model. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70555

BibTeX
@article{Su2025,
  author = {Su, Long and Hu, Xiaofang and Kumar, Ankit and Yang, Li},
  title = {Isofraxidin Attenuates Ischemia/Reperfusion‐Induced Neuroinflammation and Oxidative Stress Via Modulation of the TLR4/NF‐κB Signaling Pathway in Male Animal Model},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70555}
}
Kostenlos starten →